Tosaki A, Blasig I E, Pali T, Ebert B
Department of Pharmacology, University Medical School of Szeged, Hungary.
Free Radic Biol Med. 1990;8(4):363-72. doi: 10.1016/0891-5849(90)90102-o.
The purpose of this study was to use a direct method, that of electron spin resonance (ESR) spectroscopy, to demonstrate that reperfusion after a period of ischemia results in a sudden increase in the production of free radicals in the myocardium. Furthermore, the role of free radicals in the development of reperfusion arrhythmias and functional disturbances also was investigated using a 30-min period of global ischemia followed by 30 min of reperfusion in the isolated working rat heart. The spin trapping agent 5,5-dimethyl-1-pyrroline-1-oxide (DMPO) when it perfused the heart, 100 mumoles/liter, during the first 10 min of reperfusion attenuated the development of reperfusion arrhythmias and improved the functional recovery of the heart during reperfusion. Without treatment, 55% of hearts showed irreversible ventricular fibrillation, and this was completely prevented by DMPO. In DMPO-treated hearts, the recovery of heart function was improved; thus, coronary flow, aortic flow, left ventricular developed pressure, and first derivative of left ventricular developed pressure were significantly increased from their maximal control values of 16.2 +/- 1.9 ml/min, 12.7 +/- 0.9 ml/min, 11.1 +/- 0.5 kPa, and 426 +/- 31 kPa/s to 21.8 +/- 1.3 ml/min (p less than 0.05), 28.4 +/- 3.0 ml/min (p less than 0.001), 14.5 +/- 1.0 kPa (p less than 0.01), and 584 +/- 41 kPa/s (p less than 0.01), respectively. Left ventricular end-diastolic pressure was also significantly reduced from its control value of 2.8 +/- 0.2 kPa to 2.1 +/- 0.2 kPa (p less than 0.05), while the recovery of heart rate was not improved by DMPO treatment. Parallel ESR studies using DMPO as spin trap demonstrated the formation of .OH radicals in the effluent of the reperfused hearts. ESR signals of the formed DMPO-OH, alpha N = alpha beta H = 1.48 mT, were observed within the first seconds of reperfusion with peak concentrations after about 3 min. In the first series of ESR studies, DMPO (200 mmol/liter) was mixed up effluent and ESR signals were recorded, while in the second series of studies, DMPO was directly infused into the heart. Both methods were appropriate to demonstrate the radical formation that peaked at 3 min of reperfusion after 30 min of global ischemia. Cardiotoxic effects of DMPO can be excluded by using of the "mix-up" method (DMPO is added to effluent) because relatively high DMPO concentration (20-200 mmol/liter) is important for demonstration of free radical production.(ABSTRACT TRUNCATED AT 400 WORDS)
本研究的目的是采用一种直接方法,即电子自旋共振(ESR)光谱法,来证明缺血一段时间后的再灌注会导致心肌中自由基生成突然增加。此外,还利用离体工作大鼠心脏进行30分钟全心缺血后再灌注30分钟的模型,研究了自由基在再灌注心律失常和功能紊乱发生过程中的作用。自旋捕获剂5,5 - 二甲基 - 1 - 吡咯啉 - 1 - 氧化物(DMPO)在再灌注的最初10分钟以100微摩尔/升的浓度灌注心脏时,可减轻再灌注心律失常的发生,并改善再灌注期间心脏的功能恢复。未经处理时,55%的心脏出现不可逆室颤,而DMPO可完全预防这种情况。在DMPO处理的心脏中,心脏功能的恢复得到改善;因此,冠状动脉血流量、主动脉血流量、左心室舒张末压和左心室舒张末压的一阶导数分别从其最大对照值16.2±1.9毫升/分钟、12.7±0.9毫升/分钟、11.1±0.5千帕和426±31千帕/秒显著增加至21.8±1.3毫升/分钟(p<0.05)、28.4±3.0毫升/分钟(p<0.001)、14.5±1.0千帕(p<0.01)和584±41千帕/秒(p<0.01)。左心室舒张末压也从其对照值2.8±0.2千帕显著降低至2.1±0.2千帕(p<0.05),而DMPO处理并未改善心率的恢复。使用DMPO作为自旋捕获剂的平行ESR研究表明,再灌注心脏流出液中形成了·OH自由基。在再灌注的最初几秒内即可观察到形成DMPO - OH的ESR信号,αN =αβH = 1.48毫特斯拉,约3分钟后达到峰值浓度。在第一系列ESR研究中,将DMPO(200毫摩尔/升)与流出液混合并记录ESR信号,而在第二系列研究中,将DMPO直接注入心脏。两种方法均适用于证明在30分钟全心缺血后再灌注3分钟时达到峰值的自由基形成。使用“混合”方法(将DMPO添加到流出液中)可排除DMPO的心脏毒性作用,因为相对较高的DMPO浓度(20 - 200毫摩尔/升)对于证明自由基产生很重要。(摘要截选至400字)